A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanoma (Q73805325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337677%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337677%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

6 November 2019

main subject

1 reference

A Messori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337677%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Becagli

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337677%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S Trippoli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337677%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

E Tendi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337677%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337677%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337677%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337677%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337677%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

1373-1379

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337677%20AND%20SRC:MED&resulttype=core&format=json

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide+methotrexate+fluorouracil in patients with node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Cost effectiveness of adjuvant intraportal chemotherapy in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

The cost effectiveness of preoperative autologous blood donations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Results of adjuvant interferon study in WHO melanoma programme

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Finally, a successful adjuvant therapy for high-risk melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Assessment of quality-of-life outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Survival curve fitting using the Gompertz function: a methodology for conducting cost-effectiveness analyses on mortality data

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Meta-analysis of clinical trials based on censored end-points: simplified theory and implementation of the statistical algorithms on a microcomputer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

Adjuvant therapy for stage III colon cancer: economics returns to research and cost-effectiveness of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900413-3

7 January 2021

10.1016/S0959-8049(96)00413-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337677%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference